Article
Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects.
Journal of acquired immune deficiency syndromes (1999) - 15 Dec 2008
Robertson Sarah M, Maldarelli Frank, Natarajan Ven, Formentini Elizabeth, Alfaro Raul M, Penzak Scott R
Abstract excerpt
OBJECTIVE: To characterize the effect of efavirenz on bupropion hydroxylation as a marker of cytochrome P450 (CYP) 2B6 activity in healthy subjects. METHODS: Thirteen subjects received a single oral dose of bupropion SR 150 mg before and after 2 weeks of efavirenz administration for comparison of bupropion and hydroxybupropion pharmacokinetics. Efavirenz plasma concentrations were also assessed. Subjects were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
